๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The regulation and function of p21ras during T-cell activation and growth

โœ Scribed by Manolo Izquierdo Pastor; Karin Reif; Doreen Cantrell


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
798 KB
Volume
16
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Involvement of p21ras activation in T ce
โœ Daniele d'Ambrosio; Doreen A. Cantrell; Luigi Frati; Angela Santoni; Roberto Tes ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 577 KB

## Involvement of p2lraS activation in T cell CD69 expression The involvement of p21ras in the induction of the early activation antigen CD69 was investigated in T cells. Expression of a v-Ha-rus coding for a constitutively active ras protein in Jurkat cells resulted in CD69 induction on the cell

Regulation of hepatocyte growth: Alpha-1
โœ Jennifer L. Cruise; Stephanie J. Muga; Yi-Sheng Lee; George K. Michalopoulos ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 636 KB

Catecholamines, acting via the alpha-l adrenergic receptor, have been demonstrated to influence adult rat hepatocyte DNA synthesis in primary culture and in vivo during liver regeneration following partial hepatectomy (PHX). Earlier investigations have suggested that the alpha-1 effect on DNA synthe

Pyrimido-pyrimidine modulation of EGF gr
โœ Rosemarie B. Lichtner; Gary E. Gallick; Garth L. Nicolson ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 804 KB

RA 233, a pyrimido-pyrimidine analogue developed originally as an antiplatelet agent, has reduced the incidence of tumor metastases in clinical trials. However, in animal tumor models antimetastatic therapy using RA 233 has been inconsistent. We therefore tested RA 233 for additional effects, such a

Arotinoid mofarotene (RO40-8757) up-regu
โœ Shigeyuki Kawa; Toshio Nikaido; Yuji Aoki; Yali Zhai; Toshiko Kumagaya; Kenichi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 165 KB

Effective chemotherapy for pancreatic cancer is urgently needed. The anti-proliferative activity of a new retinoid, mofarotene (RO40-8757), was compared with that of other retinoids, such as all trans-retinoic acid, 13-cis retinoic acid and 9-cis retinoic acid, on 9 pancreatic cancer cell lines in r